Z1 Hip System: Post-Market Clinical Follow Up Study
← catalyst calendarNCT07104279 · readout ≤ 743 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
150estimated
Sites
2
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-10-13 | actual | When the study began enrolling |
| Primary completion | Aug 2028 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Aug 2031 | estimated | The whole study's end, after follow-up |
| First posted | 2025-08-05 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-11-10 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Hip Osteoarthritis
- Acute Traumatic Fracture of the Femoral Head or Neck
- Avascular Necrosis of the Femoral Head
Intervention
- Device: Z1 Femoral Hip System
Primary outcome
what the primary-completion date above is the date OF2 Year Survivorship
measured 2 years post-operative
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed